Elizabeth Pretzer

586 total citations
17 papers, 492 citations indexed

About

Elizabeth Pretzer is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Elizabeth Pretzer has authored 17 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 11 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Elizabeth Pretzer's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and RNA Interference and Gene Delivery (4 papers). Elizabeth Pretzer is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and RNA Interference and Gene Delivery (4 papers). Elizabeth Pretzer collaborates with scholars based in United States, Portugal and Belgium. Elizabeth Pretzer's co-authors include Nejat Düzgüneş, John E. Wiktorowicz, Krystyna Konopka, Kamala Tyagarajan, Diana Flasher, Vladimir Slepushkin, Sérgio Simões, Maria C. Pedroso de Lima, Philip L. Felgner and Paul Dazin and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Elizabeth Pretzer

17 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Pretzer United States 13 279 127 121 76 64 17 492
Gillian M. Schiralli Lester United States 9 298 1.1× 142 1.1× 72 0.6× 82 1.1× 108 1.7× 16 481
Marija Brgles Croatia 14 279 1.0× 59 0.5× 64 0.5× 171 2.3× 54 0.8× 38 500
François M. Pujol Finland 12 335 1.2× 149 1.2× 59 0.5× 30 0.4× 137 2.1× 13 657
R. M. VALERIO Australia 9 432 1.5× 303 2.4× 106 0.9× 75 1.0× 124 1.9× 11 650
Otto O. Yang United States 9 286 1.0× 91 0.7× 78 0.6× 17 0.2× 104 1.6× 17 566
Shuihong Cheng China 13 301 1.1× 76 0.6× 59 0.5× 22 0.3× 32 0.5× 27 535
Nathan I. Nicely United States 14 415 1.5× 330 2.6× 127 1.0× 33 0.4× 273 4.3× 25 807
Beatriz Apellániz Spain 15 408 1.5× 245 1.9× 89 0.7× 22 0.3× 108 1.7× 28 582
Steven J. Hawrylik United States 7 301 1.1× 234 1.8× 266 2.2× 13 0.2× 31 0.5× 8 563
Dylan Harris United States 14 393 1.4× 250 2.0× 227 1.9× 44 0.6× 28 0.4× 15 594

Countries citing papers authored by Elizabeth Pretzer

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Pretzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Pretzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Pretzer more than expected).

Fields of papers citing papers by Elizabeth Pretzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Pretzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Pretzer. The network helps show where Elizabeth Pretzer may publish in the future.

Co-authorship network of co-authors of Elizabeth Pretzer

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Pretzer. A scholar is included among the top collaborators of Elizabeth Pretzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Pretzer. Elizabeth Pretzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pretzer, Elizabeth & John E. Wiktorowicz. (2007). Saturation fluorescence labeling of proteins for proteomic analyses. Analytical Biochemistry. 374(2). 250–262. 32 indexed citations
2.
Düzgüneş, Nejat, Sérgio Simões, Vladimir Slepushkin, et al.. (2005). Delivery of Antiviral Agents in Liposomes. Methods in enzymology on CD-ROM/Methods in enzymology. 391. 351–373. 17 indexed citations
3.
Tyagarajan, Kamala, Elizabeth Pretzer, & John E. Wiktorowicz. (2003). Thiol‐reactive dyes for fluorescence labeling of proteomic samples. Electrophoresis. 24(14). 2348–2358. 84 indexed citations
4.
Ghosh, Arun K., et al.. (2002). Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease. Antiviral Research. 54(1). 29–36. 22 indexed citations
5.
Düzgüneş, Nejat, Sérgio Simões, Vladimir Slepushkin, et al.. (2001). ENHANCED INHIBITION OF HIV-1 REPLICATION IN MACROPHAGES BY ANTISENSE OLIGONUCLEOTIDES, RIBOZYMES AND ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS DELIVERED IN pH-SENSITIVE LIPOSOMES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 515–523. 27 indexed citations
6.
Düzgüneş, Nejat, Elizabeth Pretzer, Sérgio Simões, et al.. (1999). Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Molecular Membrane Biology. 16(1). 111–118. 35 indexed citations
7.
Simões, Sérgio, Vladimir Slepushkin, Elizabeth Pretzer, et al.. (1999). Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. Journal of Leukocyte Biology. 65(2). 270–279. 65 indexed citations
8.
Konopka, Krystyna, et al.. (1999). Secretory Leukocyte Protease Inhibitor (SLPI): Oxidation of SLPI Does Not Explain Its Variable Anti-HIV Activity. Journal of Dental Research. 78(12). 1773–1776. 9 indexed citations
10.
Konopka, Krystyna, Elizabeth Pretzer, Philip L. Felgner, & Nejat Düzgüneş. (1996). Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1312(3). 186–196. 72 indexed citations
11.
Konopka, Krystyna, et al.. (1995). A monoclonal antibody to the gp120-CD4 complex has differential effects on HIV-induced syncytium formation and viral infectivity. Journal of General Virology. 76(3). 669–679. 13 indexed citations
12.
Düzgüneş, Nejat, Diana Flasher, Elizabeth Pretzer, et al.. (1995). Liposome-mediated therapy of human immunodeficiency virus type-1 and mycobacterium infections. Journal of Liposome Research. 5(4). 669–691. 7 indexed citations
13.
Konopka, Krystyna, et al.. (1995). Differential Effects of a Hydrophobic Tripeptide on Human Immunodeficiency Virus Type 1 (HIV-1)-Induced Syncytium Formation and Viral Infectivity. Biochemical and Biophysical Research Communications. 208(1). 75–81. 9 indexed citations
14.
Pretzer, Elizabeth, Diana Flasher, & Nejat Düzgüneş. (1995). Inhibition of HIV-1 infection of macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease. Antiviral Research. 26(3). A358–A358. 3 indexed citations
15.
Flasher, Diana, Krystyna Konopka, Steven M. Chamow, et al.. (1994). Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochimica et Biophysica Acta (BBA) - Biomembranes. 1194(1). 185–196. 24 indexed citations
17.
Rest, Richard F. & Elizabeth Pretzer. (1981). Degradation of gonococcal outer membrane proteins by human neutrophil lysosomal proteases. Infection and Immunity. 34(1). 62–68. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026